对容量复苏后休克或脓毒症患者高钠血症的积极纠正建议应持保留态度:一项系统评价
该系统评价检索了MEDLINE、Embase、Cochrane CENTRAL、Cochrane系统评价数据库、ClinicalTrials.gov、Index-Catalogue of the Library of the Surgeon General's Office、DARE和CINAHL等数据库及参考文献列表,寻找评估积极干预将容量复苏后休克和/或脓毒症患者的高钠血症纠正至血钠正常对任何结局影响的随机或观察性对照研究。结果未找到任何随机或观察性对照试验测量复苏患者中积极纠正高钠血症对任何结局的影响。作者结论认为,对复苏后脓毒症或休克患者积极纠正高钠血症的推荐缺乏被现代证据标准接受的临床研究支持。
要点
- 系统评价未找到任何随机或观察性对照试验评估积极纠正容量复苏后休克/脓毒症患者高钠血症对结局的影响。
- healthcare-acquired hypernatremia定义为血清钠>145 mEq/dL,在危重患者中常见,通常用低渗液体和/或利尿剂纠正「自由水缺乏」。
- 许多高钠血症患者为等容量或高容量,且不断有文献强调危重患者复苏后快速恢复中性液体平衡的重要性。
- 作者结论:对复苏后脓毒症或休克患者积极纠正高钠血症的推荐缺乏被现代证据标准接受的临床研究支持。
适用人群与场景
- 容量复苏后的休克和/或脓毒症患者。
诊断标准与关键阈值
- healthcare-acquired hypernatremia定义为血清钠>145 mEq/dL。
研究设计与关键结果
- 系统评价检索MEDLINE、Embase、Cochrane Central Register of Controlled Trials、Cochrane Database of Systematic Reviews、ClinicalTrials.gov、Index-Catalogue of the Library of the Surgeon General's Office、DARE和CINAHL等数据库及参考文献列表,未找到任何随机或观察性对照试验评估积极纠正高钠血症对复苏患者任何结局的影响。
证据类型、等级与局限
- 证据类型:系统评价;未找到符合纳入标准的随机或观察性对照试验。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,对复苏后脓毒症或休克患者积极纠正高钠血症的推荐缺乏被现代证据标准接受的临床研究支持。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Healthcare-acquired hypernatremia (serum sodium >145 mEq/dL) is common among critically ill and other hospitalized patients and is usually treated with hypotonic fluid and/or diuretics to correct a "free water deficit." However, many hypernatremic patients are eu- or hypervolemic, and an evolving body of literature emphasizes the importance of rapidly returning critically ill patients to a neutral fluid balance after resuscitation.
OBJECTIVE: We searched for any randomized- or observational-controlled studies evaluating the impact of active interventions intended to correct hypernatremia to eunatremia on any outcome in volume-resuscitated patients with shock and/or sepsis.
DATA SOURCES: We performed a systematic literature search with studies identified by searching MEDLINE, Embase, Cochrane Central Register of Controlled Trials, Cochrane Database of Systematic Reviews, ClinicalTrials.gov, Index-Catalogue of the Library of the Surgeon General's Office, DARE (Database of Reviews of Effects), and CINAHL and scanning reference lists of relevant articles with abstracts published in English.
DATA SYNTHESIS: We found no randomized- or observational-controlled trials measuring the impact of active correction of hypernatremia on any outcome in resuscitated patients.
CONCLUSION: Recommendations for active correction of hypernatremia in resuscitated patients with sepsis or shock are unsupported by clinical research acceptable by modern evidence standards.
参考来源
- Quinn JW, Sewell K, Simmons DE, et al. Recommendations for active correction of hypernatremia in volume-resuscitated shock or sepsis patients should be taken with a grain of salt: A systematic review. SAGE Open Med. 2018. PMID: 29593868. doi:10.1177/2050312118762043
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。